Osteoporosis Trial, Recruiting NCT07677072 Sponsor: Kanuni Sultan Suleyman Training and Research Hospital Condition: Osteoporosis
Back to Osteoporosis

Osteoporosis Trial, Recruiting

NCT07677072
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are female
  • People aged 45 years or older
  • People who have gone through menopause
  • People who are already attending a Physical Medicine and Rehabilitation outpatient clinic
  • People who are already having a routine bone density scan (DEXA) and related blood tests for osteoporosis as part of their care
  • People who are willing and able to sign a written consent form

Who may not be able to join:

  • People who have not yet gone through menopause
  • People whose bone loss is caused by another condition, such as cancer, advanced kidney disease, severe liver disease, or certain hormone or gland disorders
  • People who currently have an active infection or an acute inflammatory condition
  • People who have had major surgery within the past 6 months
  • People who have a neurological or muscular condition that significantly affects how their muscles work
  • People who would not be able to follow the study procedures and complete the required assessments
  • People who are currently taking medications that strongly affect bone health, such as bisphosphonates, denosumab, teriparatide, or similar treatments for osteoporosis
  • People who are unwilling or unable to sign a written consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Dilek Ün oguzhanasiltürk, MD, Kanuni Sultan and Süleyman Training Resarch Hospital

Phone: +90 5056367184

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Kanuni Sultan Suleyman Training and Research Hospital
Registry
ClinicalTrials.gov
Start date
15 May 2026
Est. completion
1 December 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Serum Lumican Level and Bone Mineral Density Association

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov